Allergan Divests To Get FTC Greenlight For $63B AbbVie Deal
Allergan will sell off two of its medications in the hopes of swaying U.S. and European regulators to greenlight its plan to be bought out by AbbVie for $63 billion, the...To view the full article, register now.
Already a subscriber? Click here to view full article